The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, stomach flu and COVID-19.

The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...

Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

RSV and the flu have taken hold as Chicago residents have partaken in festivities in the last several weeks, and COVID is ...

Also called the “stomach bug” or “stomach flu,” norovirus tends to surge during the winter months. A national surge of ...

Newsweek has created a map showing states where respiratory syncytial virus (RSV) cases are surging.

Mask requirements and visitor restrictions have been implemented at OSF HealthCare hospitals to help slow the spread of respiratory illnesses.

The National Center for Disease Control (NCDC) has announced the extension of the seasonal influenza vaccination campaign ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity do not respond as strongly ...

RSV is spread through droplets in the air when the infected cough or sneeze and can be passed on by touching a surface ...

BARS-13 is under clinical development by Beijing Advaccine Biotechnology and currently in Phase II for Respiratory Syncytial Virus (RSV) Infections.